Skip Navigation


JAC Advance Access originally published online on January 28, 2005
Journal of Antimicrobial Chemotherapy 2005 55(3):383-386; doi:10.1093/jac/dki002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/3/383    most recent
dki002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kerrn, M. B.
Right arrow Articles by Krogfelt, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerrn, M. B.
Right arrow Articles by Krogfelt, K. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

JAC vol.55 no.3 © The British Society for Antimicrobial Chemotherapy 2005; all rights reserved

Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice

M. B. Kerrn1,2,*, C. Struve1, J. Blom3, N. Frimodt-Møller2 and K. A. Krogfelt1

1 Department of Bacteriology, Mycology and Parasitology, 2 National Center of Antimicrobials and Infection Control and 3 Department of Virology, Statens Serum Institut, Copenhagen, Denmark


* Correspondence address. Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. Tel: +45-32683593; Fax: +45-32688431; Email: mbp{at}ssi.dk

Objectives: It has been suggested recently that intracellular bacteria surviving antibiotic treatment might serve as a reservoir for recurrent infection. The purpose of this study was to directly examine the location of Escherichia coli bacteria in the mouse bladder after treatment with mecillinam.

Methods: The bladders were studied by use of colony counts, in situ hybridization and electron microscopy.

Results: The bacterial counts in the bladder remained ~103–4 cfu/bladder even after mecillinam treatment had finished, and re-growth in the urine was observed. In the bladder epithelium from treated mice, bacteria cells were occasionally seen, presumably representing intracellularly located bacteria.

Conclusions: This is the first in vivo study indicating that during mecillinam treatment E. coli cells can penetrate the mouse bladder epithelium and persist.

Keywords: UTIs , mouse models , antibiotic treatments


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
R. E. Berry, D. J. Klumpp, and A. J. Schaeffer
Urothelial Cultures Support Intracellular Bacterial Community Formation by Uropathogenic Escherichia coli
Infect. Immun., July 1, 2009; 77(7): 2762 - 2772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Dhakal and M. A. Mulvey
Uropathogenic Escherichia coli Invades Host Cells via an HDAC6-modulated Microtubule-dependent Pathway
J. Biol. Chem., January 2, 2009; 284(1): 446 - 454.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. U. Mysorekar and S. J. Hultgren
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract
PNAS, September 19, 2006; 103(38): 14170 - 14175.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Ejrnaes, D. Sandvang, B. Lundgren, S. Ferry, S. Holm, T. Monsen, R. Lundholm, and N. Frimodt-Moller
Pulsed-Field Gel Electrophoresis Typing of Escherichia coli Strains from Samples Collected before and after Pivmecillinam or Placebo Treatment of Uncomplicated Community-Acquired Urinary Tract Infection in Women.
J. Clin. Microbiol., May 1, 2006; 44(5): 1776 - 1781.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.